Clinical Trials | April 05, 2024
Merck initiates Phase 3 clinical trial of investigational oral KRAS G12C inhibitor MK-1084
For the first-line treatment of certain patients with metastatic non-small cell lung cancer
For the first-line treatment of certain patients with metastatic non-small cell lung cancer
Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus
Executes the first project for developing and manufacturing a novel anticancer mAb
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
The Convocation ceremony was organized for students skilled and certified in Ayush
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
Subscribe To Our Newsletter & Stay Updated
